Saccharomyces boulardii Tht 500101 changes gut microbiota and ameliorates hyperglycaemia, dyslipidaemia, and liver inflammation in streptozotocin-diabetic mice.

Type 1 diabetes mellitus (T1DM) is a disorder resulting from chronic autoimmune destruction of insulin-producing pancreatic ß-cells, lack of insulin production and hyperglycaemia. The aim of this study was to evaluate the hypothesis that streptozotocin-diabetic mice treated with Saccharomyces boulardii THT 500101 strain present improvement of glucose and triglycerides metabolism, reduction of liver inflammation concomitant with a beneficial impact in the gut microbiota profile. C57BL/6 male mice were randomly assigned into three groups: Control, Diabetes, Diabetes+Probiotic, and were euthanised 8 weeks after probiotic chronic administration. Mice submitted to treatment presented reduced glycemia in comparison with the diabetic group, which was correlated with an increase in C-peptide level and in hepatic glycogen content. Fat metabolism was significantly altered in streptozotocin-induced diabetic group, and S. boulardii treatment regulated it, leading to a decrease in serum triglycerides secretion, increase in hepatic triglycerides storage and modulation of inflammatory profile. The phenotypic changes seen from chronic S. boulardii treatment were found to be broadly associated with the changes in microbioma of diabetic animals, with increased proportion in Bacteroidetes, Firmicutes and Deferribacteres, and a decreased proportion of Proteobacteria and Verrucomicrobia phylum. Thus, the data presented here show up a novel potential therapeutic role of S. boulardii for the treatment and attenuation of diabetes-induced complications.

Assessment of tooth sensitivity using a desensitizer before light-activated bleaching.

UNLABELLED: CLINICAL OBJECTIVE: This clinical study evaluated whether the use of a desensitizing agent (5% potassium nitrate/2% sodium fluoride) before in-office light-activated bleaching decreased this sensitivity. METHODS: Before in-office bleaching with 35% hydrogen peroxide gel (three applications, 15 minutes each) associated with an LED/laser unit, clinicians applied a placebo gel or the desensitizing agent on the buccal surfaces of all participants. They repeated this protocol one week later. Patients recorded their tooth sensitivity on a 0-to-4 scale. The authors used one-way repeated measures ANOVA to compare the tooth color changes and non-parametric statistics to compare the different percentages of patients with tooth sensitivity and the levels of tooth sensitivity in the different periods of time between groups (α=0.05). RESULTS: The use of a desensitizing gel did not affect the bleaching efficacy. Eighty percent and 100% of the participants from the experimental and placebo groups, respectively, experienced tooth sensitivity (p>0.05). The intensity of sensitivity was similar immediately after bleaching for both groups (p>0.05). After 24 hours, lower sensitivity was reported in the experimental group, while most of the participants from the placebo group experienced tooth sensitivity (p<0.05).